What is a multidisciplinary tumor board and should my Prostate Cancer case be presented

Understanding Multidisciplinary Tumor Boards for Prostate Cancer

What Is a Multidisciplinary Tumor Board?

A multidisciplinary tumor board (also called a molecular tumor board) is a team of different medical specialists who meet together to review and discuss a patient's cancer case. Rather than seeing doctors one at a time, this collaborative approach brings together experts from different fields to develop a comprehensive treatment plan tailored to your specific situation.

Who typically participates:

• Medical oncologists (cancer specialists)
• Urologists (specialists in urinary and reproductive systems)
• Radiation oncologists (radiation therapy specialists)
• Pathologists (specialists who analyze tissue samples)
• Radiologists (imaging specialists)
• Nurses and other support staff
• Sometimes bioinformaticians (specialists who analyze genetic data)

Why This Matters for Advanced Prostate Cancer

According to the CancerPatientLab webinars on prostate cancer care, the multidisciplinary approach is particularly valuable because it integrates multiple types of information about your cancer:

The integration principle: As discussed in "Multi-omic Analysis Guides the Decisions of Brian McCloskey," doctors should "balance and integrate data from the research and the test reports, considering patient history, current treatments and clinical context when interpreting reports." A tumor board does exactly this—it brings together different perspectives to see your cancer from multiple angles.

Should Your Case Be Presented?

You should strongly consider requesting a tumor board presentation if:

1. You have advanced or metastatic prostate cancer (cancer that has spread beyond the prostate)
2. Your cancer is castrate-resistant (no longer responding to hormone therapy)
3. You have complex genomic testing results (genetic mutations, biomarkers, or multi-omic analysis like RNA sequencing, DNA sequencing, or spatial analysis)
4. Your treatment isn't working as expected or you're facing difficult treatment decisions
5. You want to explore clinical trial options
6. Your cancer shows unusual features (like neuroendocrine transformation or rare mutations)

Real-World Example from Prostate Cancer Patients

Brian McCloskey, an advanced prostate cancer patient featured in the CancerPatientLab webinars, exemplifies why tumor boards matter. His case involved:

• Complex multi-omic analysis showing neuroendocrine transformation
• Multiple biomarkers (VEGF pathway, synaptophysin expression, HER2/HER3)
• Conflicting data between standard pathology and advanced molecular testing
• Multiple treatment options to evaluate

According to the webinar "Multi-omic Analysis Guides the Decisions of Brian McCloskey," Dr. [removed] McKay "completely quarterbacked his care across the emergency department, the urology team, the radiation oncology team, her team, and orthopedic surgery." This coordinated, multidisciplinary approach helped integrate all his complex data into a coherent treatment strategy.

Key Strategic Principles Applied in Tumor Boards

When your case is presented, the team typically considers:

• Outcome goals: Quality of life AND delaying disease progression
• Targeting vulnerabilities: Identifying specific weaknesses in YOUR tumor that drugs can target
• Safety: Avoiding toxic drug combinations while maximizing effectiveness
• Sequencing: Planning which treatments to use now and which to reserve for later
• Access: Considering what treatments are realistically available to you
• Validation: Confirming test results through multiple methods before making major decisions

How to Request a Tumor Board Presentation

Steps to take:

1. Ask your oncologist directly: "Would my case benefit from a multidisciplinary tumor board review?"
2. Provide your complete medical information: pathology reports, imaging results, genetic testing, treatment history
3. Request written recommendations: Ask for a summary of the board's discussion and recommendations
4. Bring the summary to your next appointment: Use it to guide conversations with your care team

Important Consideration: Finding the Right "Quarterback"

The webinars emphasize a critical point: you need a physician who is willing and able to integrate complex molecular data. As stated in "Multi-omic Analysis Guides the Decisions of Brian McCloskey":

"Choose a quarterback for your care who is well-versed in the research and connected with you. (It may be hard to find medical oncologists like Dr. [removed]Kay who are willing or able to integrate complex molecular testing data into their practice)."

This means:

• Your primary oncologist should be comfortable discussing advanced testing results
• They should be willing to collaborate with other specialists
• They should explain their reasoning in ways you can understand
• Red flag: If your oncologist dismisses advanced testing or won't discuss treatment options, this may be a sign to seek a second opinion

Questions to Ask Your Oncologist

1. "Do you think my case would benefit from a multidisciplinary tumor board review?"
2. "What specific aspects of my cancer would the board help clarify?"
3. "How would the board's recommendations change my current treatment plan?"
4. "Can you help me access a tumor board at a major cancer center if my current hospital doesn't have one?"
5. "Would you be willing to integrate advanced molecular testing (like RNA sequencing or spatial analysis) into my treatment decisions?"

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.